171 related articles for article (PubMed ID: 30102520)
1. Generation and Comparative Kinetic Analysis of New Glycosynthase Mutants from Streptococcus pyogenes Endoglycosidases for Antibody Glycoengineering.
Tong X; Li T; Li C; Wang LX
Biochemistry; 2018 Sep; 57(35):5239-5246. PubMed ID: 30102520
[TBL] [Abstract][Full Text] [Related]
2. Glycosynthase Mutants of Endoglycosidase S2 Show Potent Transglycosylation Activity and Remarkably Relaxed Substrate Specificity for Antibody Glycosylation Remodeling.
Li T; Tong X; Yang Q; Giddens JP; Wang LX
J Biol Chem; 2016 Aug; 291(32):16508-18. PubMed ID: 27288408
[TBL] [Abstract][Full Text] [Related]
3. Site-specific immobilization of endoglycosidases for streamlined chemoenzymatic glycan remodeling of antibodies.
Li T; Li C; Quan DN; Bentley WE; Wang LX
Carbohydr Res; 2018 Mar; 458-459():77-84. PubMed ID: 29475193
[TBL] [Abstract][Full Text] [Related]
4. Generation of efficient mutants of endoglycosidase from Streptococcus pyogenes and their application in a novel one-pot transglycosylation reaction for antibody modification.
Iwamoto M; Sekiguchi Y; Nakamura K; Kawaguchi Y; Honda T; Hasegawa J
PLoS One; 2018; 13(2):e0193534. PubMed ID: 29474426
[TBL] [Abstract][Full Text] [Related]
5. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.
Huang W; Giddens J; Fan SQ; Toonstra C; Wang LX
J Am Chem Soc; 2012 Jul; 134(29):12308-18. PubMed ID: 22747414
[TBL] [Abstract][Full Text] [Related]
6. One-pot enzymatic glycan remodeling of a therapeutic monoclonal antibody by endoglycosidase S (Endo-S) from Streptococcus pyogenes.
Tong X; Li T; Orwenyo J; Toonstra C; Wang LX
Bioorg Med Chem; 2018 Apr; 26(7):1347-1355. PubMed ID: 28789910
[TBL] [Abstract][Full Text] [Related]
7. Development of glycosynthases with broad glycan specificity for the efficient glyco-remodeling of antibodies.
Shivatare SS; Huang LY; Zeng YF; Liao JY; You TH; Wang SY; Cheng T; Chiu CW; Chao P; Chen LT; Tsai TI; Huang CC; Wu CY; Lin NH; Wong CH
Chem Commun (Camb); 2018 Jun; 54(48):6161-6164. PubMed ID: 29809215
[TBL] [Abstract][Full Text] [Related]
8. Generation of a Mutant Mucor hiemalis Endoglycosidase That Acts on Core-fucosylated N-Glycans.
Katoh T; Katayama T; Tomabechi Y; Nishikawa Y; Kumada J; Matsuzaki Y; Yamamoto K
J Biol Chem; 2016 Oct; 291(44):23305-23317. PubMed ID: 27629418
[TBL] [Abstract][Full Text] [Related]
9. Remarkable transglycosylation activity of glycosynthase mutants of endo-D, an endo-β-N-acetylglucosaminidase from Streptococcus pneumoniae.
Fan SQ; Huang W; Wang LX
J Biol Chem; 2012 Mar; 287(14):11272-81. PubMed ID: 22318728
[TBL] [Abstract][Full Text] [Related]
10. Endo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins.
Giddens JP; Lomino JV; Amin MN; Wang LX
J Biol Chem; 2016 Apr; 291(17):9356-70. PubMed ID: 26966183
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into the mechanisms and specificities of IgG-active endoglycosidases.
Du JJ; Klontz EH; Guerin ME; Trastoy B; Sundberg EJ
Glycobiology; 2020 Mar; 30(4):268-279. PubMed ID: 31172182
[TBL] [Abstract][Full Text] [Related]
12. Chemoenzymatic Glycan Remodeling of Natural and Recombinant Glycoproteins.
Yang Q; Wang LX
Methods Enzymol; 2017; 597():265-281. PubMed ID: 28935106
[TBL] [Abstract][Full Text] [Related]
13. Site-selective chemoenzymatic glycoengineering of Fab and Fc glycans of a therapeutic antibody.
Giddens JP; Lomino JV; DiLillo DJ; Ravetch JV; Wang LX
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12023-12027. PubMed ID: 30397147
[TBL] [Abstract][Full Text] [Related]
14. Enhanced transglycosylation activity of an Endo-F3 mutant by ligand-directed localization.
Zou X; Liu Z; Liu L; Shi W; Li W; Guo Z; Tang F; Huang W
Org Biomol Chem; 2022 Apr; 20(15):3086-3095. PubMed ID: 35166761
[TBL] [Abstract][Full Text] [Related]
15. Mutants of Mucor hiemalis endo-beta-N-acetylglucosaminidase show enhanced transglycosylation and glycosynthase-like activities.
Umekawa M; Huang W; Li B; Fujita K; Ashida H; Wang LX; Yamamoto K
J Biol Chem; 2008 Feb; 283(8):4469-79. PubMed ID: 18096701
[TBL] [Abstract][Full Text] [Related]
16. Glycosynthases enable a highly efficient chemoenzymatic synthesis of N-glycoproteins carrying intact natural N-glycans.
Huang W; Li C; Li B; Umekawa M; Yamamoto K; Zhang X; Wang LX
J Am Chem Soc; 2009 Feb; 131(6):2214-23. PubMed ID: 19199609
[TBL] [Abstract][Full Text] [Related]
17. Glycan Remodeling of Human Erythropoietin (EPO) Through Combined Mammalian Cell Engineering and Chemoenzymatic Transglycosylation.
Yang Q; An Y; Zhu S; Zhang R; Loke CM; Cipollo JF; Wang LX
ACS Chem Biol; 2017 Jun; 12(6):1665-1673. PubMed ID: 28452462
[TBL] [Abstract][Full Text] [Related]
18. Chemoenzymatic Defucosylation of Therapeutic Antibodies for Enhanced Effector Functions Using Bacterial α-Fucosidases.
Li C; Li T; Wang LX
Methods Mol Biol; 2018; 1827():367-380. PubMed ID: 30196507
[TBL] [Abstract][Full Text] [Related]
19. Glycosynthase activity of Bacillus licheniformis 1,3-1,4-beta-glucanase mutants: specificity, kinetics, and mechanism.
Faijes M; Pérez X; Pérez O; Planas A
Biochemistry; 2003 Nov; 42(45):13304-18. PubMed ID: 14609341
[TBL] [Abstract][Full Text] [Related]
20. Transglycosidase-like activity of Mucor hiemalis endoglycosidase mutants enabling the synthesis of glycoconjugates using a natural glycan donor.
Sakaguchi K; Katoh T; Yamamoto K
Biotechnol Appl Biochem; 2016 Nov; 63(6):812-819. PubMed ID: 26381157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]